Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus

Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase

Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells

Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus

Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus

Genetically engineered Newcastle disease virus for malignant melanoma therapy

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses

Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses

The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer

Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice